Jeffrey H Buchalter - Net Worth and Insider Trading
Jeffrey H Buchalter Net Worth
The estimated net worth of Jeffrey H Buchalter is at least $35,805 dollars as of 2024-11-13. Jeffrey H Buchalter is the Chairman, CEO & President, Director of Enzon Pharmaceuticals Inc and owns about 453,234 shares of Enzon Pharmaceuticals Inc (ENZN) stock worth over $35,805. Details can be seen in Jeffrey H Buchalter's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey H Buchalter has not made any transactions after 2008-11-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey H Buchalter
Jeffrey H Buchalter Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey H Buchalter owns 1 companies in total, including Enzon Pharmaceuticals Inc (ENZN) .
Click here to see the complete history of Jeffrey H Buchalter’s form 4 insider trades.
Insider Ownership Summary of Jeffrey H Buchalter
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENZN | Enzon Pharmaceuticals Inc | 2008-11-13 | director & Chairman & CEO & President |
Jeffrey H Buchalter Latest Holdings Summary
Jeffrey H Buchalter currently owns a total of 1 stock. Jeffrey H Buchalter owns 453,234 shares of Enzon Pharmaceuticals Inc (ENZN) as of November 13, 2008, with a value of $35,805.
Latest Holdings of Jeffrey H Buchalter
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENZN | Enzon Pharmaceuticals Inc | 2008-11-13 | 453,234 | 0.08 | 35,805 |
Holding Weightings of Jeffrey H Buchalter
Jeffrey H Buchalter Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey H Buchalter has made a total of 0 transactions in Enzon Pharmaceuticals Inc (ENZN) over the past 5 years. The most-recent trade in Enzon Pharmaceuticals Inc is the acquisition of 50,000 shares on November 13, 2008, which cost Jeffrey H Buchalter around $164,000.
Insider Trading History of Jeffrey H Buchalter
- 1
Jeffrey H Buchalter Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey H Buchalter's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey H Buchalter is 38.49%. GuruFocus also compares Jeffrey H Buchalter's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey H Buchalter within 3 months outperforms 4 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey H Buchalter's insider trading performs compared to the benchmark.
Performance of Jeffrey H Buchalter
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 31.03 | | | | | |
| Relative Return to S&P 500(%) | 29.96 | | | | | |
Jeffrey H Buchalter Ownership Network
Ownership Network List of Jeffrey H Buchalter
Ownership Network Relation of Jeffrey H Buchalter
Jeffrey H Buchalter Owned Company Details
What does Enzon Pharmaceuticals Inc do?
Who are the key executives at Enzon Pharmaceuticals Inc?
Jeffrey H Buchalter is the director & Chairman & CEO & President of Enzon Pharmaceuticals Inc. Other key executives at Enzon Pharmaceuticals Inc include other: See Footnote 1 Family Fund Couchman , other: See explanation of responses Brian James Harper , and other: See explanation of responses Harper Asset Management Llc .
Enzon Pharmaceuticals Inc (ENZN) Insider Trades Summary
Over the past 18 months, Jeffrey H Buchalter made no insider transaction in Enzon Pharmaceuticals Inc (ENZN). Other recent insider transactions involving Enzon Pharmaceuticals Inc (ENZN) include a net purchase of 99,550 shares made by Randolph C Read ,
In summary, during the past 3 months, insiders sold 0 shares of Enzon Pharmaceuticals Inc (ENZN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Enzon Pharmaceuticals Inc (ENZN) were sold and 99,550 shares were bought by its insiders, resulting in a net purchase of 99,550 shares.
Enzon Pharmaceuticals Inc (ENZN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enzon Pharmaceuticals Inc Insider Transactions
Jeffrey H Buchalter Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey H Buchalter. Currently GuruFocus does not have mailing address information for Jeffrey H Buchalter.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
